Systemic and Intraocular Methotrexate for the Prevention and Treatment of Proliferative Vitreoretinopathy in Children With Rhegmatogenous Retinal Detachment and Underlying Inflammatory Disease.

Journal of vitreoretinal diseases(2022)

引用 0|浏览1
暂无评分
摘要
The safety and efficacy of this combination therapy suggests that it could be a successful strategy for treating pediatric patients with RRD with or without PVR in the presence or absence of underlying inflammatory diseases.
更多
查看译文
关键词
immunosuppression,inflammation,methotrexate,pediatric rhegmatogenous retinal detachment (RRD),proliferative vitreoretinopathy (PVR)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要